Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
10%
Ph phase_2
1
10%
Ph phase_1
1
10%
Ph not_applicable
7
70%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(2)
Other(4)

Detailed Status

unknown4
Not yet recruiting2
Completed2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 31 (10.0%)
N/A7 (70.0%)

Trials by Status

recruiting110%
enrolling_by_invitation110%
unknown440%
not_yet_recruiting220%
completed220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10